#1 Startup Dataset
Growth rates, revenue data, direct competitors and contact details.
Craig Shimasaki Email
Co-Founder, President and CEO . Moleculera Biosciences
How to contact Craig Shimasaki
Join and see Craig's contact info for free!Current Roles
Employees:
16Revenue:
$2.5MAbout
Moleculera Biosciences is a precision medicine company focused on identifying and directing treatment for immune-mediated causes of chronic debilitating disorders. Through our fully-accredited CLIA/COLA clinical laboratory, we specialize in molecular diagnostic testing for autoimmune neuroimmunology. As pioneers focusing on neuropsychiatric disorders caused by molecular mimicry, we offer the Autoimmune Brain Panel™, an aid to a physician’s diagnosis of autoimmune-based neuropsychiatric disorders.\n\nThe Autoimmune Brain Panel™ helps identify whether an individual’s neurologic/psychiatric symptoms, such as obsessive compulsive behaviors, tics, anxiety, attention deficit hyperactivity disorder, and sometimes behaviors associated with Autism Spectrum Disorders, could be caused by a treatable autoimmune condition triggered by common infections.Moleculera Biosciences Address
Oklahoma City, OK
United States